Global Antipyretic Drug Market 2025-2035

Description

List of Tables

Global Antipyretic Drug Market Size, Share & Trends Analysis Report by Type (Paracetamol, Ibuprofen, Aspirin, NSAID, and Others), by Sales Type (Prescription and Over the Counter (OTC)), by Sales Channels (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies, and Others) Forecast Period (2025-2035)

Industry Outlook

Antipyretic drug market is expected to grow at a CAGR of 7.5% during the forecast period. An antipyretic is a pharmaceutical ingredient that helps in reducing fever. Antipyretics cause the hypothalamus to override a prostaglandin-induced increase in temperature. The market is growing owing to the growing number of bacterial and viral infections globally, and medical treatment costs have seen dramatic growth globally. In recent years increasing demand for over-the-counter (OTC) medications such as acetaminophen and ibuprofen, as well as prescription-strength pain relievers. These medications are in high demand owing to the rising incidence of ailments, including migraine and arthritis, as well as a growing emphasis on self-medication. Topical patches and extended-release tablets are two instances of novel formulations and delivery systems that are improving patient compliance and treatment efficacy, which is propelling market expansion.

Segmental Outlook

The global antipyretic drug market is segmented by type, sales type, and sales channels. Based on the type, the market is sub-segmented into Paracetamol, Ibuprofen, Aspirin, NSAID, and others. Based on the sales type, the market is sub-segmented into prescription and OTC. Further, based on dosage form, the market is sub-segmented into Tablet, Syrup, Injection, and Paste. Based on sales channels, the market is sub-segmented into hospital pharmacies, drug store & retail pharmacies, online pharmacies, and others.

The Over-counter (OTC) Sub-Segment Is Anticipated to Hold a Considerable Share of the Global Antipyretic Drug Market

It is projected that the over-the-counter (OTC) subsegment will account for a sizeable portion of the global antipyretic drug market owing to its accessibility, cost, and growing consumer desire for self-medication. The fact that common medications such as aspirin, ibuprofen, and paracetamol are accessible without a prescription makes them practical for treating pain and fever. Demand has also increased as fever-related disorders such as the flu and viral infections have grown more common. Strong marketing plans and regulatory clearances from organizations such as the FDA and EMA also help the industry expand. As over-the-counter medications are less expensive than prescription equivalents, customers find them appealing. The market is predicted to continue to dominate as self-care habits continue to grow, despite worries about abuse and overdose hazards.

Regional Outlook

The global antipyretic drug market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, Russia, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, Australia & New Zealand, ASEAN Countries and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America).

The Asia-Pacific Region is Expected to Grow During the Projected Years

The market indicates high growth in the Asia-Pacific region owing to the high demand for OTC drugs in the antipyretic market. Rising incidences of infectious diseases, flu during seasons, and viral fevers have spurred the demand for antipyretic drugs. Also, the increasing awareness of self-medication, combined with the universal availability of Over-the-Counter (OTC) medications, has been driving market growth. The rapid growth in the pharmacy industry, increasing the healthcare infrastructure, and increasing disposable incomes are also driving the trend. Furthermore, the expansion of e-commerce and the initiatives of the government towards healthcare accessibility have enhanced sales, which have made Asia-Pacific the fastest-growing region for the antipyretic drug market.

Market Players Outlook

The major companies serving the antipyretic drug market include Johnson & Johnson Services, Inc., Bristol-Myers Squibb Co., Reckitt Benckiser's Global, Procter & Gamble, AdvaCare Pharma, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market.

The Report Covers:

Market value data analysis of 2025 and forecast to 2035.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global antipyretic drug market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where' in the market.

Product Code: OMR2027476

1. Report Summary

Current Industry Analysis and Growth Potential Outlook
Global Antipyretic Drug Market Sales Analysis - Type | Category Type| Sales Channel ($ Million)
1.1. Research Methodology
Primary Research Approach
Secondary Research Approach

2. Market Overview and Insights

2.1. Scope of the Study
2.2. Analyst Insight & Current Market Trends
- 2.2.1. Key Global Antipyretic Drug Market Trends
- 2.2.2. Market Recommendations
- 2.2.3. Conclusion

3. Market Determinants

3.1. Market Drivers
- 3.1.1. Drivers For Global Antipyretic Drug Market: Impact Analysis
3.2. Market Pain Points and Challenges
- 3.2.1. Restraints For Global Antipyretic Drug Market: Impact Analysis
3.3. Market Opportunities

4. Competitive Landscape

4.1. Competitive Dashboard - Global Antipyretic Drug Market Revenue by Manufacturers
4.2. Key Company Analysis
- 4.2.1. Overview
- 4.2.2. Product Portfolio
- 4.2.3. Financial Analysis (Subject to Data Availability)
- 4.2.4. SWOT Analysis
- 4.2.5. Business Strategy
4.3. Top Winning Strategies by Market Players
- 4.3.1. Merger and Acquisition
- 4.3.2. Product Launch
- 4.3.3. Partnership And Collaboration

5. Global Antipyretic Drug Market by Type ($ Million)

5.1. Paracetamol
5.2. Ibuprofen
5.3. Non-Steroidal Anti-Inflammatory Drugs (NSAID)
5.4. Others

6. Global Antipyretic Drug Market by Category Type ($ Million)

6.1. Prescription (Rx)
6.2. Over the Counter (OTC)

7. Global Antipyretic Drug Market by Sales Channel ($ Million)

7.1. Hospital Pharmacies
7.2. Drug Store & Retail Pharmacies
7.3. Online Pharmacies
7.4. Others (Supermarkets)

8. Regional Analysis

North American Antipyretic Drug Market Sales Analysis Type | Category Type| Sales Channel | Country ($ Million)
- 8.1.1. United States
- 8.1.2. Canada
European Antipyretic Drug Market Sales Analysis Type | Category Type| Sales Channel | Country ($ Million)
- 8.1.3. UK
- 8.1.4. Germany
- 8.1.5. Italy
- 8.1.6. Spain
- 8.1.7. France
- 8.1.8. Russia
- 8.1.9. Rest of Europe
Asia-Pacific Antipyretic Drug Market Sales Analysis Type | Category Type| Sales Channel | Country ($ Million)
- 8.1.10. China
- 8.1.11. Japan
- 8.1.12. South Korea
- 8.1.13. India
- 8.1.14. Australia & New Zealand
- 8.1.15. ASEAN Countries (Thailand, Indonesia, Vietnam, Singapore, And Other)
- 8.1.16. Rest of Asia-Pacific
Rest of the World Antipyretic Drug Market Sales Analysis Type | Category Type| Sales Channel | Country ($ Million)
- 8.1.17. Latin America
- 8.1.18. Middle East and Africa

9. Company Profiles

9.1. AdvaCare Pharma
9.2. Alembic Pharmaceuticals Ltd.
9.3. Bayer CropScience Limited
9.4. Bristol-Myers Squibb Co.
9.5. Cadila Healthcare Ltd. (Zydus)
9.6. Dr. Reddy's Laboratories Ltd.
9.7. GlaxoSmithKline. (GSK)
9.8. Glenmark Pharmaceuticals Inc.
9.9. Hetero Healthcare Ltd.
9.10. Johnson & Johnson Services, Inc.
9.11. Kryptomed Formulations Pvt. Ltd
9.12. Lion Corp.
9.13. LUPIN Ltd.
9.14. Lustre Pharmaceutical Pvt. Ltd.
9.15. Macleods Pharmaceuticals Ltd.
9.16. Manish Pharma Lab
9.17. Procter & Gamble
9.18. Reckitt Benckiser's Global
9.19. Sanofi S.A.
9.20. Saphnix Life Sciences